[1] |
Costa-Moreira P,Vilas-Boas F,Teixeira Fraga A,et al.Particular aspects of gastroenterological disorders in chronic kidney disease and end-stage renal disease patients:a clinically focused review[J].Scand J Gastroenterol,2020,55(2):129-138.
|
[2] |
Kalman RS,Pedrosa MC.Evidence-based review of gastrointestinal bleeding in the chronic kidney disease patient[J].Semin Dial,2015,28(1): 68-74.
|
[3] |
Lin Y,Li C,Waters D,et al.Gastrointestinal bleeding in chronic kidney disease patients:a systematic review and meta-analysis[J].Ren Fail,2023,45(2):2276908.
|
[4] |
Hágendorn R,Farkas N,Vincze á,et al.Chronic kidney disease severely deteriorates the outcome of gastrointestinal bleeding:A meta-analysis[J].World J Gastroenterol,2017,23(47):8415-8425.
|
[5] |
García Agudo R,Aoufi Rabih S,González Carro P,et al.Lesiones gastrointestinales en pacientes con enfermedad renal crónicay anemia[J].Nefrología,2019,39(1):50-57.
|
[6] |
Parasa S,Navaneethan U,Sridhar AR,et al.End-stage renal disease is associated with worse outcomes in hospitalized patients with peptic ulcer bleeding[J].Gastrointest Endosc,2013,77(4):609-616.
|
[7] |
Kim M,Kim CS,Bae EH,et al.Risk factors for peptic ulcer disease in patients with end-stage renal disease receiving dialysis[J].Kidney Res Clin Pract,2019,38(1):81-89.
|
[8] |
吕昂,吴鹏波,谭诗云.合并慢性肾脏病的消化性溃疡患者的临床及胃镜下特征分析[J].医学研究杂志,2022,51(3):24-27.
|
[9] |
Verma S,Attallah MA,Jarrin Jara MD,et al.Angiodysplasia in Renal Disease Patients:Analysis of Risk Factors and Approach to Manage Such Patients[J].Cureus,2020,12(8):e9784.
|
[10] |
Zajjari YTM,Montasser D,Hassani K,et al.Gastrointestinal bleeding due to angiodysplasia in patients on hemodialysis:A single-center study[J].Saudi J Kidney Dis Transpl,2016,27(4):748-751.
|
[11] |
Hung HJ,Chung CS,Tai CM,et al.Clinical characteristics and risk factors for rebleeding in uremic patients with obscure gastrointestinal bleeding undergoing deep enteroscopy:A multicenter retrospective study in Taiwan[J].PLoS One,2022,17(11): e0277434.
|
[12] |
Yuste C,Mérida E,Hernández E,et al.Gastrointestinal complications induced by sevelamer crystals[J].Clin Kidney J,2017,10(4):539-544.
|
[13] |
Rysz J,Franczyk B,Ławiński J,et al.The Impact of CKD on Uremic Toxins and Gut Microbiota[J].Toxins,2021,13(4):252.
|
[14] |
Lutz J,Menke J,Sollinger D,et al.Haemostasis in chronic kidney disease[J].Nephrol Dial Transplant,2014,29(1):29-40.
|
[15] |
Georgopoulou GA,Papasotiriou M,Bosgana P,et al.Altered Expression of Intestinal Tight Junctions in Patients with Chronic Kidney Disease: A Pathogenetic Mechanism of Intestinal Hyperpermeability[J].Biomedicines,2024,12(2):368.
|
[16] |
Paronen I,Ala-Kaila K,Rantala I,et al.Gastric parietal,chief,and G-cell densities in chronic renal failure [J].Scand J Gastroenterol,1991,26(7):696-700.
|
[17] |
王曾,张阳,王琴,等.肾性贫血并发症的研究进展[J].中国血液净化,2022,21(7):469-472.
|
[18] |
Huang CH,Chao JY,Ling TC,et al.Effect of dialysis modalities on risk of hospitalization for gastrointestinal bleeding[J].Sci Rep,2023,13(1):52.
|
[19] |
Thekkedath UR,Chirananthavat T,Leypoldt JK,et al.Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-Ⅲa [J].Am J Hematol,2006,81(12):915-926.
|
[20] |
Yaoi H,Shida Y,Ogiwara K,et al.Role of red blood cells in the anemia-associated bleeding under high shear conditions[J].Haemophilia,2017,23(5):750-758.
|
[21] |
Galanopoulos G.Angiodysplastic lesions as a cause of colonic bleeding in patients with chronic renal disease: is there an association? [J].Saudi J Kidney Dis Transpl,2012,23(5):925-928.
|
[22] |
Nambiar S,Pillai UK,Devasahayam J,et al.Colonic Mucosal Ulceration and Gastrointestinal Bleeding Associated with Sevelamer Crystal Deposition in a Patient with End Stage Renal Disease[J].Case Rep Nephrol,2018,2018: 4708068.
|
[23] |
Kim DB,Chung WC,Lee SJ,et al.Analysis of risk factor and clinical characteristics of angiodysplasia presenting as upper gastrointestinal bleeding[J].Korean J Intern Med,2016,31(4):669-677.
|
[24] |
Chen C,Liu L,Wang CY,et al.A pilot study of ultrasound evaluation of gastric emptying in patients with end-stage renal failure:a comparison with healthy controls[J].Anaesthesia,2017,72(6):714- 718.
|
[25] |
Sharma S,Raman P,Deo AS.Comparative preoperative sonological assessment of gastric contents in patients with chronic kidney disease versus those with normal renal function - A prospective observational study[J].Indian J Anaesth,2023,67(6):503-508.
|
[26] |
贾宁,唐艳萍,李杨.现代医学对胃食管反流病研究机制进展[J].中国中西医结合外科杂志,2020,26(1):179-183.
|
[27] |
Costa-Moreira P,Vilas-Boas F,Teixeira Fraga A,et al.Particular aspects of gastroenterological disorders in chronic kidney disease and end-stage renal disease patients:a clinically focused review[J].Scand J Gastroenterol,2020,55(2):129-138.
|
[28] |
Saheb Sharif-Askari F,Syed Sulaiman SA,Saheb Sharif-Askari N.Anticoagulation Therapy in Patients with Chronic Kidney Disease [J].Adv Exp Med Biol,2017,906: 101-114.
|
[29] |
Chan CT,Chang SS,Yeh EK,et al.Upper gastrointestinal bleeding in an end-stage renal disease patient treated with fluoxetine[J].Gen Hosp Psychiatry,2011,33(5):530-531,e533.
|
[30] |
Marinescu DLM,Zaharie S,Comanescu C,et al.Upper Gastrointestinal Bleeding in Chronic Kidney Disease Patients[J].Curr Health Sci J,2016,42(3):226-230.
|
[31] |
殷宝存,付泽鹏,陈君玉.艾司奥美拉唑治疗尿毒症并发上消化道出血的临床有效性及安全性分析[J].现代诊断与治疗,2023,34(15): 2238-2241.
|
[32] |
Qiu Z,Pang X,Xiang Q,et al.The Crosstalk between Nephropathy and Coagulation Disorder:Pathogenesis,Treatment,and Dilemmas[J].J Am Soc Nephrol,2023,34(11):1793-1811.
|
[33] |
王丽红,韩彬.质子泵抑制剂对慢性肾脏病患者上消化道出血临床效果的Meta 分析[J].系统医学,2024,9(3):1-7.
|
[34] |
Desbuissons G,Mercadal L.Use of proton pump inhibitors in dialysis patients:a double-edged sword? [J].J Nephrol,2021,34(3): 661-672.
|
[35] |
Borawski B,Malyszko JS,Kwiatkowska M,et al.Current Status of Renal Anemia Pharmacotherapy-What Can We Offer Today[J].J Clin Med,2021,10(18) : 4149.
|
[36] |
Nair S,Trivedi M.Anemia management in dialysis patients:a PIVOT and a new path? [J].Curr Opin Nephrol Hypertens,2020,29(3): 351-355.
|
[37] |
Wang B,Yin Q,Han YC,et al.Effect of hypoxia-inducible factorprolyl hydroxylase inhibitors on anemia in patients with CKD:a meta-analysis of randomized controlled trials including 2804 patients [J].Renal Failure,2020,42(1):912-925.
|
[38] |
Asai M,Kumakura S,Kikuchi M.Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients[J].Ren Fail,2019,41(1):47-56.
|
[39] |
Chou CY,Wang SM,Chang PH,et al.Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis[J].Int J Clin Pract,2015,69(7): 722-728.
|